VITALIZE.Use and effectiveness of Sodium Zirconium Cyclosilicate (LokelmaTM) in the real-world setting in Spain - VITALIZE

Study identifier:D9480R00047

ClinicalTrials.gov identifier:N/A

EudraCT identifier:N/A

CTIS identifier:N/A

Will Be Recruiting

Official Title

A non-interVentional, multI-center and longiTudinAL study to describe the use of SodIum Zirconium CyclosilicatE (LokelmaTM) in patients diagnosed with hyperkalemia in the real-world setting in Spain: VITALIZE study

Medical condition

Hyperkalaemia

Phase

N/A

Healthy volunteers

No

Study drug

-

Sex

All

Estimated Enrollment

230

Study type

Observational

Age

18 Years - n/a

Date

Study Start Date: 30 Sept 2024
Estimated Primary Completion Date: 31 Oct 2024
Estimated Study Completion Date: 31 Oct 2024

Study design

Allocation: N/A
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -

Verification:

Verified 01 Sept 2024 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria